MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 6911-6920 Newer>
The Motley Fool
November 29, 2010
Jim Royal
Rising Star Buy: Sabra Health Care REIT A newly spunoff company offers big dividends. mark for My Articles 6 similar articles
Fast Company
November 2010
Susan Evans
Exporting Your Plastic Surgery: Lifescience Alley Conference and Expo The number of people jumping on a plane to go under the knife is surging - in the U.S. alone, medical tourism is growing 35% each year. Plastic surgery, which makes up one-third of these trips, will be much discussed at this Minneapolis expo. Here, we look at where people go to get pretty. mark for My Articles 19 similar articles
The Motley Fool
November 26, 2010
Seth Jayson
Has Express Scripts Made You Any Real Money? With questionable cash flows amounting to only 8.1% of operating cash flow, Express Scripts' cash flows look clean. mark for My Articles 765 similar articles
The Motley Fool
November 26, 2010
Anders Bylund
Teva Is Running Scared A personal take on the MS medicine market: A little bit of marketing spin keeps the doctor away, but too much makes you a jerk. mark for My Articles 197 similar articles
The Motley Fool
November 26, 2010
Brian Orelli
Black Friday Biotech Bargains Drugmakers on sale. mark for My Articles 1307 similar articles
The Motley Fool
November 26, 2010
Brian Orelli
Get It Together, Johnson & Johnson Another day, another recall. mark for My Articles 592 similar articles
Chemistry World
November 25, 2010
Hayley Birch
Designing safer stents for heart patients A study by UK researchers provides insights into how the body reacts to the metal stents used to wedge open blocked blood vessels in heart patients. mark for My Articles 134 similar articles
The Motley Fool
November 25, 2010
Seth Jayson
Don't Get Too Worked Up Over Gilead's Earnings With questionable cash flows amounting to only 5.5% of operating cash flow, Gilead's cash flows look clean. mark for My Articles 695 similar articles
BusinessWeek
November 24, 2010
Tom Randall
Merck May Have a Cholesterol Winner Merck told doctors at the American Heart Assn. annual meeting that new data showed its drug anacetrapib had reduced bad cholesterol by 40 percent while raising good cholesterol by an unprecedented 138 percent. mark for My Articles 676 similar articles
The Motley Fool
November 24, 2010
Brian Orelli
Profit From the United States of Diabetes Half the country could have an early form by 2020. mark for My Articles 879 similar articles
<Older 6911-6920 Newer>    Return to current articles.